Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results